Viewing Study NCT03489369


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:49 PM
Study NCT ID: NCT03489369
Status: COMPLETED
Last Update Posted: 2021-02-18
First Post: 2018-03-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
Sponsor: Symphogen A/S
Organization: